• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗黄病毒体液免疫应答在保护和发病机制中的作用。

The role of anti-flavivirus humoral immune response in protection and pathogenesis.

机构信息

Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Ciudad de Mexico, Mexico.

出版信息

Rev Med Virol. 2020 Jul;30(4):e2100. doi: 10.1002/rmv.2100. Epub 2020 Feb 26.

DOI:10.1002/rmv.2100
PMID:32101633
Abstract

Flavivirus infections are a public health threat in the world that requires the development of safe and effective vaccines. Therefore, the understanding of the anti-flavivirus humoral immune response is fundamental to future studies on flavivirus pathogenesis and the design of anti-flavivirus therapeutics. This review aims to provide an overview of the current understanding of the function and involvement of flavivirus proteins in the humoral immune response as well as the ability of the anti-envelope (anti-E) antibodies to interfere (neutralizing antibodies) or not (non-neutralizing antibodies) with viral infection, and how they can, in some circumstances enhance dengue virus infection on Fc gamma receptor (FcγR) bearing cells through a mechanism known as antibody-dependent enhancement (ADE). Thus, the dual role of the antibodies against E protein poses a formidable challenge for vaccine development. Also, we discuss the roles of antibody binding stoichiometry (the concentration, affinity, or epitope recognition) in the neutralization of flaviviruses and the "breathing" of flavivirus virions in the humoral immune response. Finally, the relevance of some specific antibodies in the design and improvement of effective vaccines is addressed.

摘要

黄病毒感染是全球公共卫生的威胁,需要开发安全有效的疫苗。因此,了解抗黄病毒体液免疫反应对于未来研究黄病毒发病机制和设计抗黄病毒疗法至关重要。本综述旨在概述目前对黄病毒蛋白在体液免疫反应中的功能和参与的理解,以及包膜(抗 E)抗体干扰(中和抗体)或不干扰(非中和抗体)病毒感染的能力,以及它们如何在某些情况下通过一种称为抗体依赖性增强 (ADE) 的机制增强 Fcγ受体 (FcγR) 携带细胞中的登革热病毒感染。因此,针对 E 蛋白的抗体的双重作用给疫苗开发带来了巨大挑战。此外,我们还讨论了抗体结合计量(浓度、亲和力或表位识别)在中和黄病毒和黄病毒病毒粒子在体液免疫反应中的“呼吸”中的作用。最后,还讨论了一些特定抗体在有效疫苗的设计和改进中的相关性。

相似文献

1
The role of anti-flavivirus humoral immune response in protection and pathogenesis.抗黄病毒体液免疫应答在保护和发病机制中的作用。
Rev Med Virol. 2020 Jul;30(4):e2100. doi: 10.1002/rmv.2100. Epub 2020 Feb 26.
2
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.人类对黄病毒抗体反应的光明面和黑暗面:对疫苗设计的启示。
EMBO Rep. 2018 Feb;19(2):206-224. doi: 10.15252/embr.201745302. Epub 2017 Dec 27.
3
Molecular basis of antibody-mediated neutralization and protection against flavivirus.抗体介导的黄病毒中和及保护作用的分子基础
IUBMB Life. 2016 Oct;68(10):783-91. doi: 10.1002/iub.1556. Epub 2016 Sep 7.
4
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.解析抗病毒中和抗体反应:对疫苗开发和免疫的影响
Microbiol Mol Biol Rev. 2016 Oct 26;80(4):989-1010. doi: 10.1128/MMBR.00024-15. Print 2016 Dec.
5
A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.一场数字游戏:黄病毒感染抗体介导中和作用的化学计量学
Prog Mol Biol Transl Sci. 2015;129:141-66. doi: 10.1016/bs.pmbts.2014.10.005. Epub 2014 Dec 1.
6
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.抗体介导的黄病毒感染中和机制的结构见解:对疫苗开发的启示
Cell Host Microbe. 2008 Sep 11;4(3):229-38. doi: 10.1016/j.chom.2008.08.004.
7
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.一种经包膜修饰的四价登革病毒样颗粒疫苗对黄病毒疫苗设计具有启示意义。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01181-17. Print 2017 Dec 1.
8
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
9
Protective immune response against newly emerging goose tembusu virus infection induced by immunization with a recombinant envelope protein.重组包膜蛋白免疫诱导的针对新出现的鹅坦布苏病毒感染的保护性免疫反应
Lett Appl Microbiol. 2015 Oct;61(4):318-24. doi: 10.1111/lam.12459. Epub 2015 Aug 14.
10
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.抗体介导的黄病毒感染中和作用的分子机制。
Expert Rev Mol Med. 2008 May 12;10:e12. doi: 10.1017/S1462399408000665.

引用本文的文献

1
Comparison of Three Chimeric Zika Vaccine Prototypes Developed on the Genetic Background of the Clinically Proven Live-Attenuated Japanese Encephalitis Vaccine SA-14-2.在临床验证的减毒活疫苗日本脑炎疫苗SA - 14 - 2的基因背景上开发的三种嵌合寨卡疫苗原型的比较。
Int J Mol Sci. 2024 Dec 29;26(1):195. doi: 10.3390/ijms26010195.
2
Cold and hot tumors: from molecular mechanisms to targeted therapy.冷肿瘤和热肿瘤:从分子机制到靶向治疗。
Signal Transduct Target Ther. 2024 Oct 18;9(1):274. doi: 10.1038/s41392-024-01979-x.
3
Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants.
经修饰的膜锚定区域设计的寨卡 DNA 疫苗及其佐剂联合应用增强了小鼠的免疫原性和保护效力。
Front Immunol. 2024 Jan 19;15:1307546. doi: 10.3389/fimmu.2024.1307546. eCollection 2024.
4
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections.新兴虫媒病毒感染治疗性单克隆抗体的研发。
Viruses. 2023 Oct 30;15(11):2177. doi: 10.3390/v15112177.
5
Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain.通过突变独特抗原域开发低交叉反应性黄病毒亚病毒颗粒。
Appl Microbiol Biotechnol. 2023 Dec;107(24):7515-7529. doi: 10.1007/s00253-023-12817-5. Epub 2023 Oct 13.
6
Co-Circulation of West Nile, Usutu, and Tick-Borne Encephalitis Viruses in the Same Area: A Great Challenge for Diagnostic and Blood and Organ Safety.西尼罗病毒、乌苏图病毒和蜱传脑炎病毒在同一地区共同传播:对诊断以及血液和器官安全的巨大挑战。
Viruses. 2023 Jan 27;15(2):366. doi: 10.3390/v15020366.
7
and arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns.并且虫媒病毒 MHC Ⅰ类限制性表位特征揭示了免疫优势和较差的重叠模式。
Front Immunol. 2022 Nov 17;13:1035515. doi: 10.3389/fimmu.2022.1035515. eCollection 2022.
8
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.评价 SARS-CoV-2 感染中抗体依赖的 Fc 介导的病毒进入与中和作用的比较。
Front Immunol. 2022 May 31;13:901217. doi: 10.3389/fimmu.2022.901217. eCollection 2022.
9
A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice.一种波瓦桑病毒结构域 III 纳米颗粒免疫原在小鼠中诱导产生中和和保护抗体。
PLoS Pathog. 2022 Jun 9;18(6):e1010573. doi: 10.1371/journal.ppat.1010573. eCollection 2022 Jun.
10
Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara.西尼罗河病毒与一种基于安卡拉痘苗病毒的寨卡病毒疫苗之间的低免疫交叉反应性。
Pharmaceuticals (Basel). 2022 Mar 15;15(3):354. doi: 10.3390/ph15030354.